Infantile Inflammatory Myofibroblastic Tumor of Spleen

被引：4

作者：

Thirunavukkarasu, Balamurugan ^{[1
]}

Roy, Pritam Singha ^{[2
]}

Gupta, Kirti ^{[1
]}

Sekar, Aravind ^{[1
]}

Bansal, Deepak ^{[2
]}

机构：

[1] Post Grad Inst Med Educ & Res, Histopathol, 5th Floor,A Block,Sect 12, Chandigarh 160012, India

[2] Post Grad Inst Med Educ & Res, Pediat, Chandigarh, India

来源：

FETAL AND PEDIATRIC PATHOLOGY | 2022年 / 41卷 / 03期

关键词：

Inflammatory myofibroblastic tumor; ALK; Epstein– Barr virus; spleen; ROS1; EPSTEIN-BARR-VIRUS; ROS1; ALK; REARRANGEMENTS; PSEUDOTUMOR; EXPRESSION;

D O I：

10.1080/15513815.2020.1836098

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Background: Inflammatory myofibroblastic tumor (IMT) is a mesenchymal neoplasm with unknown etiology and recurrent potential. They are widely reported in children and young adults. Nearly 50% of inflammatory myofibroblastic tumor harbor rearrangement in anaplastic lymphoma kinase (ALK) gene with the majority expressing ALK protein. ALK-negative IMTs harbor alteration in ROS1 gene in a subset of cases. Few reports have shown association of IMT with Epstein-Barr virus (EBV). Case report: We report a case of IMT of the spleen in an 18-month-old infant presenting with abdominal distention and failure to thrive. Workup for ALK-1, ROS1, and EBV small-encoded RNA in-situ hybridization using immunohistochemistry was negative. Conclusions: IMT can arise in an infant spleen.

引用

页码：475 / 479

页数：5

共 16 条

[11] Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation [J].

Ogata, Misato ;

Hatachi, Yukimasa ;

Ogata, Takatsugu ;

Satake, Hironaga ;

Imai, Yukihiro ;

Yasui, Hisateru .

INTERNAL MEDICINE, 2019, 58 (07) :1029-1032

[12] Detection of Epstein-Barr virus in an inflammatory myofibroblastic tumor of the spleen (inflammatory pseudotumor) [J].

Palomeque Jimenez, Antonio ;

Reyes Morenoa, Montserrat ;

Calzado Baeza, Salvador ;

Ranea Jimena, Sergio A. ;

Robayo Soto, Paul Sebastian .

CIRUGIA ESPANOLA, 2015, 93 (06) :E41-E43

[13] IgG4 plasma cells in inflammatory myofibroblastic tumor: inflammatory marker or pathogenic link? [J].

Saab, Shahrazadb T. ;

Hornick, Jason L. ;

Fletcher, Christopher D. ;

Olson, Sandra J. ;

Coffin, Cheryl M. .

MODERN PATHOLOGY, 2011, 24 (04) :606-612

[14] Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial [J].

Schoffski, Patrick ;

Sufliarsky, Jozef ;

Gelderblom, Hans ;

Blay, Jean-Yves ;

Strauss, Sandra J. ;

Stacchiotti, Silvia ;

Rutkowski, Piotr ;

Lindner, Lars H. ;

Leahy, Michael G. ;

Italiano, Antoine ;

Isambert, Nicolas ;

Debiec-Rychter, Maria ;

Sciot, Raf ;

Van Cann, Thomas ;

Marreaud, Sandrine ;

Nzokirantevye, Axelle ;

Collette, Sandra ;

Wozniak, Agnieszka .

LANCET RESPIRATORY MEDICINE, 2018, 6 (06) :431-441

[15]

Sholl LM, 2013, AM J SURG PATHOL, V37, P1441, DOI 10.1097/PAS.0b013e3182960fa7

[16] ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours [J].

Yamamoto, Hidetaka ;

Yoshida, Akihiko ;

Taguchi, Kenichi ;

Kohashi, Kenichi ;

Hatanaka, Yui ;

Yamashita, Atsushi ;

Mori, Daisuke ;

Oda, Yoshinao .

HISTOPATHOLOGY, 2016, 69 (01) :72-83

← 1 2 →